Online citations, reference lists, and bibliographies.
← Back to Search

Photodynamic Therapy In The Management Of Malignant Pleural Mesothelioma: A Review.

K. Moghissi, K. Dixon
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND In the past decade there have been sporadic publications on malignant pleural mesothelioma (MPM). In the present trend of multi-modal treatment for MPM we aim to evaluate the current status of photodynamic therapy (PDT) in the management of MPM through a review study. METHODS Original publications in English were the main source of the review and their material analysed in respect of patient and disease characteristics, PDT methods, mortality and morbidity and survival. Ten articles concerned with 230 patients were analysed and 35 other publications relevant to the study were used for reference. In every case PDT was used as an adjuvant to surgery whose role appeared to be a cyto-reductive procedure of debulking, pleurectomy and decortication (DPD) with/without pulmonary resection. PDT methods used two photosensitisers; Photofrin™ [630nm laser light] (6 series=170 patients) or Foscan™ [652nm laser light] (4 series=60 patients). RESULTS Overall mortality and morbidity was 7.1% (4.9% for Photofrin™ and 13.3% for Foscan™ PDT) and 48% (38% for Photofrin™ and 70% for Foscan™ PDT) respectively. Better survival was achieved for DPD and early stage disease. CONCLUSIONS Intra-operative (IOP) PDT in MPM is a safe procedure that requires more development and work regarding photosensitisers and light distribution systems for use in intra-pleural situations. The role of surgery in IOP-PDT appears to be cyto-reduction to ≤5mm residual tumour thickness in order for PDT to be used effectively. Curative intent may depend on the stage of MPM and completeness of cyto-reduction with/without pulmonary resection.
This paper references
10.1016/s0147-0272(88)80005-9
Asbestos-related malignancy.
J. Talcott (1988)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.1378/CHEST.120.4.1167
Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results.
H. Schouwink (2001)
10.1007/BF02303746
Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma
H. Pass (2006)
10.1378/CHEST.116.2.504
Advances in the treatment of malignant pleural mesothelioma.
D. Sterman (1999)
10.1016/S1010-7940(02)00735-2
The management of malignant pleural mesothelioma.
G. Maggi (2003)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
10.1016/J.JTCVS.2004.02.021
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
D. Sugarbaker (2004)
10.1016/0003-4975(94)90443-X
Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study.
H. Takita (1994)
10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W
Malignant mesothelioma of the pleura: Review of 123 patients
J. Brenner (1982)
10.1111/j.1751-1097.1987.tb04741.x
THE THEORY OF PHOTODYNAMIC THERAPY DOSIMETRY: CONSEQUENCES OF PHOTO‐DESTRUCTION OF SENSITIZER
W. Potter (1987)
Diffuse malignant pleural mesothelioma: options in surgical treatment.
J. Harvey (1995)
Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.
M. Law (1984)
10.1002/SSU.2980110507
Intracavitary photodynamic therapy for malignant pleural mesothelioma.
H. Takita (1995)
Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.
M. Huncharek (1996)
10.1016/S1010-7940(02)00273-7
The management of malignant pleural mesothelioma; single centre experience in 10 years.
T. Aziz (2002)
Photoradiation therapy for the treatment of malignant tumors.
T. Dougherty (1978)
10.1007/BF02303538
Intrapleural photodynamic therapy: Results of a phase I trial
H. Pass (2006)
10.1016/S1010-7940(96)01008-1
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
O. Soysal (1997)
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1016/S0003-4975(02)04474-0
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
J. Friedberg (2003)
10.1038/bjc.1997.468
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
P. Baas (1997)
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.1016/S0022-5223(19)36577-8
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
10.1016/S0022-5223(98)70274-0
Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.
H. Pass (1998)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1016/0011-3840(93)90029-G
Malignant pleural mesothelioma.
H. Pass (2004)
10.1183/09031936.98.12040972
Malignant pleural mesothelioma.
C. Boutin (1998)
10.1097/00000658-199609000-00005
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.
D. Sugarbaker (1996)
10.1002/(SICI)1096-9101(1996)18:1<39::AID-LSM5>3.0.CO;2-S
Intraoperative photodynamic therapy with m‐tetrahydroxyphenylchlorin for chest malignancies
H. Ris (1996)
10.1016/S1572-1000(04)00009-2
Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience.
V. Matzi (2004)
10.1016/S1010-7940(99)00350-4
The role of photodynamic therapy (PDT) in inoperable oesophageal cancer.
K. Moghissi (2000)
10.1016/S1010-7940(98)00295-4
The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases.
K. Moghissi (1999)
10.1016/J.EJCTS.2004.12.028
Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
D. Stewart (2005)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1016/S0003-4975(98)00799-1
Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up.
T. L. Moskal (1998)
10.1200/JCO.1994.12.6.1156
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar